H1N1 (Swine Flu) Vaccination Market Latest Updates by Baxter Healthcare, GlaxoSmithKline, CSL, Medimmune (Astra Zeneca), Merck & Co. Inc, Novartis, Sanofi Pasteur, Sinovac

A wide-ranging H1N1 (Swine Flu) Vaccination Market report is one of the most significant, unique, and creditable market research reports formed by focusing on specific business prerequisites. The report has been produced by firmly following commitments and deadlines to deliver the finest market report. Also, this persuasive market report acts as a great source of notable data, present market trends, future events, market environment, technological innovation, imminent technologies and the technical development in the related industry. H1N1 (Swine Flu) Vaccination Market report arranges for insights into revenue generation and sustainability initiative. A team of industry experts, brilliant researchers, innovative forecasters and knowledgeable analysts work with full devotion to endow clients with the qualitative market research.

The Global H1N1 (Swine Flu) Vaccination Market is expected to reach USD 8.26 billion by 2025, from USD 0.6 billion in 2017 growing at a CAGR of 17% during the forecast period of 2018 to 2025. Swine flu is an infection caused by H1N1 virus, also known as swine flu virus. In 2009, H1N1 had spread rapidlyaround the world, so the World Health Organization called it a pandemic. The H1N1 virus mainly affects the respiratory system including nose, lungs and throat of the infected person. H1N1 virus can be classified on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Vaccine, suspension of weakened, killed, or fragmented microorganisms or toxins or of antibodies or lymphocytes is administered primarily to prevent disease. The market for H1N1 flu is growing tremendously due to increased awareness. For instance, according to centers for disease control and prevention, in 2009 during pandemic approximately 60.8 million cases, 274,304 hospitalizations and 12,469 deaths occurred due to H1N1 swine flu. There have been tremendous technological advancements in the field of vaccination in the last decade. For instance, in 2006, U.S. Department of Health and Human Services awarded $1 billion in funding to a number of vaccine makers, including GlaxoSmithKline, Novartis, and MedImmune, to develop alternative production methods.

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-h1n1-swine-flu-vaccination-market&VC

Key Developments in the H1N1 (Swine Flu) Vaccination Market:

January 2010: The World Health Organization defended itself against allegations it overhyped the dangers of H1N1 under pressure from vaccine manufacturers at a hearing of the Council of Europe's health committee.

October, 2009: Baxter International (U.S) got approval from European Commission (EC) for marketing authorization of CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvant pandemic influenza vaccine to receive marketing authorization in the European Union.

Top Key Players Included: H1N1 (Swine Flu) Vaccination Market

Baxter Healthcare,
GlaxoSmithKline,
CSL,
Medimmune (Astra Zeneca),
Merck & Co. Inc,
Novartis,
Sanofi Pasteur,
Sinovac,
Hualan Biological Engineering Co.,
Novovax,
Commonwealth Serum Laboratories,
Zydus Cadila,
Panacea Biotec,
Shanghai Institute Of Biological Products,
Sinovac Biotech LTD Butantan Institute, Cantacuzino Institute Of Sera And Vaccine,
Changchun Institute Of Biological Product,
Crucell N.V.,
Denka Seiken Co Ltd.,
Green Cross Corp.,
Glaxosmithkline Plc

Competitive Analysis: H1N1 (Swine Flu) Vaccination Market

The global H1N1 (swine flu) vaccination market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global H1N1 (swine flu) vaccination market for global, Europe, North America, Asia Pacific and South America

Segmentation: Global H1N1 (Swine Flu) Vaccination Market

Based on treatment type, the market is segmented into:

influenza,
meningococcal,
cervical cancer,
pneumococcal,
hepatitis,
measles,
mumps,
rubella

On the basis of end user, the market is segmented into:

hospital,
clinics

Based on geography, the market report covers data points for 28 countries across multiple geographies namely:

North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

H1N1 (Swine Flu) Vaccination Market Drivers and Restraints:

Cost of H1N1 Vaccine
Vaccine awareness
Side-effects of vaccine
Availability of substitute treatment
Limited consumer segments
Ease in administration

WHY CHOOSE US

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-h1n1-swine-flu-vaccination-market&VC

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.